94 related articles for article (PubMed ID: 1109797)
1. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas.
Gupta RK; Morton DL
Cancer Res; 1975 Jan; 35(1):58-62. PubMed ID: 1109797
[TBL] [Abstract][Full Text] [Related]
2. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
3. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
[TBL] [Abstract][Full Text] [Related]
4. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
6. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
Roth JA; Grimm EA; Morton DL
Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies on malignant melanomas of man.
Romsdahl MM; Cox IS
Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
[No Abstract] [Full Text] [Related]
8. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
Kutteh WH; Doellgast GJ
J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
[TBL] [Abstract][Full Text] [Related]
9. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
10. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
12. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C
Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184
[TBL] [Abstract][Full Text] [Related]
13. [Binding of IgG and IgM class antibodies from the serum of patients with ovarian carcinoma to malignant and normal ovaries].
Stankus P; Gazárek F
Cesk Gynekol; 1983 Jun; 48(5):332-8. PubMed ID: 6352065
[No Abstract] [Full Text] [Related]
14. Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.
Gupta RK; Morton DL
J Natl Cancer Inst; 1983 Jun; 70(6):993-1004. PubMed ID: 6190035
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H
J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572
[TBL] [Abstract][Full Text] [Related]
17. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
[No Abstract] [Full Text] [Related]
19. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity.
Hellström I; Brown JP; Hellström KE
J Immunol; 1981 Jul; 127(1):157-60. PubMed ID: 6787119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
